Related Experiment Video
Updated: Jun 18, 2026

08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
15.9K
Integrated MRI-guided radiotherapy - opportunities and challenges.
Paul J Keall1, Caterina Brighi2, Carri Glide-Hurst3
1ACRF Image X Institute, The University of Sydney, Sydney, New South Wales, Australia. paul.keall@sydney.edu.au.
Nature Reviews. Clinical Oncology
|April 20, 2022
Summary
Integrated MRI-guided radiotherapy (MRIgRT) enhances cancer treatment by adapting radiation doses to tumor changes and biological features. This approach aims to improve tumor control and reduce side effects for better survival and quality of life.
Area of Science:
- Oncology
- Radiotherapy
- Medical Imaging
Background:
- Magnetic Resonance Imaging (MRI) offers high-resolution anatomical and functional tissue characterization.
- The integration of MRI with radiotherapy has led to advanced treatment devices.
- MRI-guided radiotherapy (MRIgRT) has become clinically available over the past decade.
Purpose of the Study:
- To review the current status of MRI-guided radiotherapy.
- To explore the opportunities and challenges associated with MRIgRT.
- To highlight the clinical drivers for adopting MRIgRT.
Main Methods:
- Utilizing MRI for real-time imaging of anatomical and biological tumor features.
- Implementing motion management techniques during treatment.
- Employing biological targeting to adapt radiation delivery.
Main Results:
- MRIgRT enables adaptive treatment strategies by imaging changes before and during therapy.
- The technology allows for precise targeting of aggressive tumor regions.
- Adjusting radiation dose based on real-time imaging improves tumor control probability and reduces toxicity.
Conclusions:
- MRIgRT represents a significant advancement in radiotherapy, improving treatment precision.
- The approach holds the potential to enhance patient survival and quality of life.
- Further development and implementation of MRIgRT are crucial for its widespread clinical benefit.

